GNHAY - CSL reports tender offer results of Vifor Pharma acquisition

CSL's (OTCPK:CSLLY) unit CSL Behring reported provisional results of its tender offer to acquire all publicly held shares of Vifor Pharma (OTCPK:GNHAY) for $179.25/ share in a deal valued at ~$11.7B. CSL's participation at the end of the additional acceptance period on March 22 was a total of 94% of all listed Vifor Pharma shares, subject to the completion of the offer. Australia-based CSL has already waived the 80% acceptance rate condition which was set in the offer prospectus and declared the tender offer successful in the interim result. The definitive notice of the end result is expected to be published on March 28.

For further details see:

CSL reports tender offer results of Vifor Pharma acquisition